United States Biotechnology & Medical Research

Singular Genomics Systems Inc (OMIC)

Track

Track

Ticker: OMIC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Singular Genomics Systems Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Spaventa Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
45.03
Quantity 1,646 +16.5%
Value US$2,733,399
3.5
Spaventa Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
127.89
Quantity 88,483 -25.7%
Value US$854,454
3.5
Spaventa Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
492.06
Quantity 72,828 +49.0%
Value US$4,584,290
3.3
TANG KEVIN Large shareholder
Transaction date
Purchase
Price
17.21
Quantity 32,000 +9.4%
Value US$550,720
3.3
TANG KEVIN Large shareholder
Transaction date
Purchase
Price
15.33
Quantity 40,000 +13.3%
Value US$613,200
3.3
TANG KEVIN Large shareholder
Transaction date
Purchase
Price
12.74
Quantity 50,416 +20.2%
Value US$642,300
3.5
Spaventa Andrew Chief Executive Officer Executive Director
Transaction date
Sale
Price
12.38
Quantity 175 -21.6%
Value US$2,167
3.5
Spaventa Andrew Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.42
Quantity 75,000 +1.9%
Value US$31,755
3.5
Spaventa Andrew Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.41
Quantity 43,468 +1.1%
Value US$17,857
2.0
Glezer Eli N. Chief Scientific Officer Officer
Transaction date
Purchase
Price
0.43
Quantity 200,000 +4.6%
Value US$85,640
3.9
Kim Kamdar Affiliate
Transaction date
Proposed sale
Price
0.53
Quantity 200,000
Value US$106,960
3.9
Kamdar Kim P. Non-Executive Director
Transaction date
Sale
Price
0.53
Quantity 200,000 -5.0%
Value US$106,960
3.9
Kamdar Kim P. Non-Executive Director
Transaction date
Sale
Price
0.57
Quantity 77,991 -1.9%
Value US$44,424
3.9
Kamdar Kim P. Non-Executive Director
Transaction date
Sale
Price
0.60
Quantity 353,657 -8.0%
Value US$210,603
3.9
Kim Kamdar Affiliate
Transaction date
Proposed sale
Price
0.57
Quantity 77,991
Value US$44,424
3.9
Kim Kamdar Affiliate
Transaction date
Proposed sale
Price
0.60
Quantity 353,657
Value US$210,603
2.0
Glezer Eli N. Chief Scientific Officer Officer
Transaction date
Purchase
Price
0.82
Quantity 170,000 +4.1%
Value US$138,924
2.0
Glezer Eli N. Chief Scientific Officer Officer
Transaction date
Purchase
Price
2.00
Quantity 50,000 +1.2%
Value US$100,000
3.7
Pellini Michael J Non-Executive Director
Transaction date
Purchase
Price
3.30
Quantity 26,834 +37.0%
Value US$88,552
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-14 2025-02-14 S Sale
3.5
Spaventa Andrew

Chief Executive Officer

Executive Director
1,646 +16.5%
45.03
US$2,733,399 		1,646 +16.5% 45.03 US$2,733,399
2024-12-17 2024-12-16 S Sale
3.5
Spaventa Andrew

Chief Executive Officer

Executive Director
88,483 -25.7%
127.89
US$854,454 		88,483 -25.7% 127.89 US$854,454
2024-11-13 2024-11-12 S Sale
3.5
Spaventa Andrew

Chief Executive Officer

Executive Director
72,828 +49.0%
492.06
US$4,584,290 		72,828 +49.0% 492.06 US$4,584,290
2024-09-18 2024-09-18 B Purchase
3.3
TANG KEVIN
Large shareholder
32,000 +9.4%
17.21
US$550,720 		32,000 +9.4% 17.21 US$550,720
2024-09-18 2024-09-17 B Purchase
3.3
TANG KEVIN
Large shareholder
40,000 +13.3%
15.33
US$613,200 		40,000 +13.3% 15.33 US$613,200
2024-09-18 2024-09-16 B Purchase
3.3
TANG KEVIN
Large shareholder
50,416 +20.2%
12.74
US$642,300 		50,416 +20.2% 12.74 US$642,300
2024-09-17 2024-09-15 S Sale
3.5
Spaventa Andrew

Chief Executive Officer

Executive Director
175 -21.6%
12.38
US$2,167 		175 -21.6% 12.38 US$2,167
2023-11-20 2023-11-17 B Purchase
3.5
Spaventa Andrew

Chief Executive Officer

Executive Director
75,000 +1.9%
0.42
US$31,755 		75,000 +1.9% 0.42 US$31,755
2023-11-20 2023-11-16 B Purchase
3.5
Spaventa Andrew

Chief Executive Officer

Executive Director
43,468 +1.1%
0.41
US$17,857 		43,468 +1.1% 0.41 US$17,857
2023-11-20 2023-11-16 B Purchase
2.0
Glezer Eli N.

Chief Scientific Officer

Officer
200,000 +4.6%
0.43
US$85,640 		200,000 +4.6% 0.43 US$85,640
2023-08-15 2023-08-15 PrS Proposed sale
3.9
Kim Kamdar

Affiliate
200,000
0.53
US$106,960 		200,000 0.53 US$106,960
2023-08-15 2023-08-15 S Sale
3.9
Kamdar Kim P.
Non-Executive Director
200,000 -5.0%
0.53
US$106,960 		200,000 -5.0% 0.53 US$106,960
2023-08-15 2023-08-14 S Sale
3.9
Kamdar Kim P.
Non-Executive Director
77,991 -1.9%
0.57
US$44,424 		77,991 -1.9% 0.57 US$44,424
2023-08-15 2023-08-11 S Sale
3.9
Kamdar Kim P.
Non-Executive Director
353,657 -8.0%
0.60
US$210,603 		353,657 -8.0% 0.60 US$210,603
2023-08-14 2023-08-11 PrS Proposed sale
3.9
Kim Kamdar

Affiliate
77,991
0.57
US$44,424 		77,991 0.57 US$44,424
2023-08-11 2023-08-11 PrS Proposed sale
3.9
Kim Kamdar

Affiliate
353,657
0.60
US$210,603 		353,657 0.60 US$210,603
2023-05-18 2023-05-17 B Purchase
2.0
Glezer Eli N.

Chief Scientific Officer

Officer
170,000 +4.1%
0.82
US$138,924 		170,000 +4.1% 0.82 US$138,924
2022-12-13 2022-12-12 B Purchase
2.0
Glezer Eli N.

Chief Scientific Officer

Officer
50,000 +1.2%
2.00
US$100,000 		50,000 +1.2% 2.00 US$100,000
2022-05-19 2022-05-18 B Purchase
3.7
Pellini Michael J
Non-Executive Director
26,834 +37.0%
3.30
US$88,552 		26,834 +37.0% 3.30 US$88,552
Explore more

More insider trading research around Singular Genomics Systems Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America